These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Amphotericin B in disseminated cutaneous candidiasis. COFFEY CM; EVERETT MA; KAY FR Arch Dermatol; 1961 Jun; 83():1014-5. PubMed ID: 13694283 [No Abstract] [Full Text] [Related]
8. [Monilial granuloma. Effects of amphotericin B]. DEGOS R; DROUHET E; TOURAINE R; DANA M Bull Soc Fr Dermatol Syphiligr; 1959; 5():632-7. PubMed ID: 13815415 [No Abstract] [Full Text] [Related]
9. A therapeutic comparison of amphotericin B and nystatin in cutaneous candidiasis. ROBINSON MM Mil Med; 1962 Apr; 127():345-8. PubMed ID: 14492924 [No Abstract] [Full Text] [Related]
10. Topical use of amphotericin. KNOX JM; FRASER WM Tex State J Med; 1962 Jun; 58():415-6. PubMed ID: 14457369 [No Abstract] [Full Text] [Related]
11. Monilial cystitis-effective treatment with instilations of amphotericin B. GOLDMAN HJ; LITTMAN ML; OPPENHEIMER GD; GLICKMAN SI JAMA; 1960 Sep; 174():359-62. PubMed ID: 13706544 [No Abstract] [Full Text] [Related]
12. Monilial granuloma treatment with amphotericin B and dermabrasion. ENGEL MF J Med Assoc Ga; 1962 Mar; 51():102-5. PubMed ID: 13890223 [No Abstract] [Full Text] [Related]
13. Candida albicans peritonitis successfully treated with amphotericin B. OHLWILER DA; BRICKER EM N Engl J Med; 1959 Mar; 260(10):488-9. PubMed ID: 13632916 [No Abstract] [Full Text] [Related]
14. Candida lusitaniae fungemia in cancer patients: risk factors for amphotericin B failure and outcome. Atkinson BJ; Lewis RE; Kontoyiannis DP Med Mycol; 2008 Sep; 46(6):541-6. PubMed ID: 19180749 [TBL] [Abstract][Full Text] [Related]
15. Extensive cutaneous moniliasis. Treatment with amphotericin B. BUZDYGAN D; LEPPER M; NEUHAUSER I; ROSENTHAL IM Am J Dis Child; 1961 Aug; 102():168-79. PubMed ID: 13689523 [No Abstract] [Full Text] [Related]
16. Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review. Krcmery V; Spanik S; Kunova A; Trupl J; Grausova S; Krupova I; Mateicka F; Pichnova E; Grey E; Sabo A J Chemother; 1999 Apr; 11(2):131-6. PubMed ID: 10326744 [TBL] [Abstract][Full Text] [Related]
17. High-dose liposomal amphotericin B in the therapy of systemic candidiasis in neonates. Juster-Reicher A; Flidel-Rimon O; Amitay M; Even-Tov S; Shinwell E; Leibovitz E Eur J Clin Microbiol Infect Dis; 2003 Oct; 22(10):603-7. PubMed ID: 13680398 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic action of sterosan-hydrocortisone in various superficial dermatoses, with special reference to the dermatoses caused by Candida]. POZZO G Minerva Dermatol; 1962 Mar; 37():109-13. PubMed ID: 14488434 [No Abstract] [Full Text] [Related]
19. When to suspect fungal infection in neonates: A clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Benjamin DK; Ross K; McKinney RE; Benjamin DK; Auten R; Fisher RG Pediatrics; 2000 Oct; 106(4):712-8. PubMed ID: 11015513 [TBL] [Abstract][Full Text] [Related]
20. Further clinical trials of amphotericin; with a report on the treatment of a probable case of generalised moniliasis. CHILDS AJ Scott Med J; 1959 Feb; 4(2):80-3. PubMed ID: 13635051 [No Abstract] [Full Text] [Related] [Next] [New Search]